440 related articles for article (PubMed ID: 32085732)
21. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737
[TBL] [Abstract][Full Text] [Related]
22. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
23. Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study.
Gallardo-García MM; Sánchez-Espín G; Ivanova-Georgieva R; Ruíz-Morales J; Rodríguez-Bailón I; Viñuela González V; García-López MV
Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):821-8. PubMed ID: 26951263
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.
Bae IG; Federspiel JJ; Miró JM; Woods CW; Park L; Rybak MJ; Rude TH; Bradley S; Bukovski S; de la Maria CG; Kanj SS; Korman TM; Marco F; Murdoch DR; Plesiat P; Rodriguez-Creixems M; Reinbott P; Steed L; Tattevin P; Tripodi MF; Newton KL; Corey GR; Fowler VG;
J Infect Dis; 2009 Nov; 200(9):1355-66. PubMed ID: 19811099
[TBL] [Abstract][Full Text] [Related]
25. Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Seidl K; Chen L; Bayer AS; Hady WA; Kreiswirth BN; Xiong YQ
Antimicrob Agents Chemother; 2011 Dec; 55(12):5631-9. PubMed ID: 21968365
[TBL] [Abstract][Full Text] [Related]
26. New agents for Staphylococcus aureus endocarditis.
Drees M; Boucher H
Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
[TBL] [Abstract][Full Text] [Related]
27. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
28. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
San-Juan R; Fernández-Ruiz M; Gasch O; Camoez M; López-Medrano F; Domínguez MÁ; Almirante B; Padilla B; Pujol M; Aguado JM;
J Antimicrob Chemother; 2017 Jul; 72(7):2102-2109. PubMed ID: 28379553
[TBL] [Abstract][Full Text] [Related]
29. [Investigation of infective endocarditis clinical isolates of methicillin resistant Staphylococcus aureus non-responsive to vancomycin].
Takayama Y; Yoshida K; Yamaguchi Y; Nonoyama M; Endo T; Sunakawa K
Kansenshogaku Zasshi; 2001 Jun; 75(6):473-9. PubMed ID: 11494564
[TBL] [Abstract][Full Text] [Related]
30. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
[TBL] [Abstract][Full Text] [Related]
31. Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
Hughes DW; Frei CR; Maxwell PR; Green K; Patterson JE; Crawford GE; Lewis JS
Antimicrob Agents Chemother; 2009 May; 53(5):2014-9. PubMed ID: 19258261
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
[TBL] [Abstract][Full Text] [Related]
33. Methicillin resistance in Staphylococcus aureus infections among patients colonized with methicillin-susceptible Staphylococcus aureus.
Shrestha NK; Fraser TG; Gordon SM
Clin Microbiol Infect; 2019 Jan; 25(1):71-75. PubMed ID: 29649598
[TBL] [Abstract][Full Text] [Related]
34. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
36. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
37. Development of a mouse model of induced Staphylococcus aureus infective endocarditis.
Gibson GW; Kreuser SC; Riley JM; Rosebury-Smith WS; Courtney CL; Juneau PL; Hollembaek JM; Zhu T; Huband MD; Brammer DW; Brieland JK; Sulavik MC
Comp Med; 2007 Dec; 57(6):563-9. PubMed ID: 18246868
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains.
Pintado V; Pazos R; Jiménez-Mejías ME; Rodríguez-Guardado A; Díaz-Pollán B; Cabellos C; García-Lechuz JM; Lora-Tamayo J; Domingo P; Muñez E; Domingo D; González-Romo F; Lepe-Jiménez JA; Rodríguez-Lucas C; Gil A; Pelegrín I; Chaves F; Pomar V; Ramos A; Alarcón T; Pérez-Cecilia E
J Hosp Infect; 2019 May; 102(1):108-115. PubMed ID: 30448277
[TBL] [Abstract][Full Text] [Related]
39. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
[TBL] [Abstract][Full Text] [Related]
40. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement.
Del Val D; Abdel-Wahab M; Mangner N; Durand E; Ihlemann N; Urena M; Pellegrini C; Giannini F; Gasior T; Wojakowski W; Landt M; Auffret V; Sinning JM; Cheema AN; Nombela-Franco L; Chamandi C; Campelo-Parada F; Munoz-Garcia E; Herrmann HC; Testa L; Won-Keun K; Castillo JC; Alperi A; Tchetche D; Bartorelli AL; Kapadia S; Stortecky S; Amat-Santos I; Wijeysundera HC; Lisko J; Gutiérrez-Ibanes E; Serra V; Salido L; Alkhodair A; Vendramin I; Chakravarty T; Lerakis S; Vilalta V; Regueiro A; Romaguera R; Kappert U; Barbanti M; Masson JB; Maes F; Fiorina C; Miceli A; Kodali S; Ribeiro HB; Mangione JA; Sandoli de Brito F; Actis Dato GM; Rosato F; Ferreira MC; Corriea de Lima V; Colafranceschi AS; Abizaid A; Marino MA; Esteves V; Andrea J; Godinho RR; Alfonso F; Eltchaninoff H; Søndergaard L; Himbert D; Husser O; Latib A; Le Breton H; Servoz C; Pascual I; Siddiqui S; Olivares P; Hernandez-Antolin R; Webb JG; Sponga S; Makkar R; Kini AS; Boukhris M; Gervais P; Linke A; Crusius L; Holzhey D; Rodés-Cabau J
Can J Cardiol; 2022 Jan; 38(1):102-112. PubMed ID: 34688853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
